RxNorm Semantic Concepts Index - 146
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "146".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1460194 | Piperazine derivative | Designated preferred name (PT) | NO | |
| RxCUI: 1460194 | Piperazine derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 1460194 | Piperazine derivative | Designated preferred name (PT) | NO | |
| RxCUI: 1460194 | Piperazine derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 14625 | Disproportionating enzyme | Designated preferred name (PT) | NO | |
| RxCUI: 14625 | Disproportionating enzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 14625 | Disproportionating enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 14625 | Disproportionating enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1463 | Saccharogen amylase | Designated preferred name (PT) | NO | |
| RxCUI: 1463 | Saccharogen amylase | Full form of descriptor (FN) | NO | |
| RxCUI: 1463 | Saccharogen amylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1464103 | Substance with vasopressin receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1464103 | Substance with vasopressin receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1464103 | Substance with vasopressin receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1464103 | Substance with vasopressin receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1464103 | Substance with vasopressin receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1465366 | Clopidogrel hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 1465366 | Clopidogrel hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1467016 | ormetoprim / sulfadimethoxine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 14678 | 4-4'-methylenedianiline | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 14678 | 4-4'-methylenedianiline | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 14678 | 4-4'-methylenedianiline | Designated preferred name (PT) | NO | |
| RxCUI: 14678 | 4-4'-methylenedianiline | Full form of descriptor (FN) | NO | |
| RxCUI: 14678 | 4-4'-methylenedianiline | Designated preferred name (PT) | NO | |
| RxCUI: 14678 | 4-4'-methylenedianiline | Full form of descriptor (FN) | NO | |
| RxCUI: 1467910 | Solithromycin | Designated preferred name (PT) | NO | |
| RxCUI: 1467910 | Solithromycin | Full form of descriptor (FN) | NO | |
| RxCUI: 14688 | 4,4'-dihydroxybiphenyl | Designated preferred name (PT) | NO | |
| RxCUI: 14688 | 4,4'-dihydroxybiphenyl | Full form of descriptor (FN) | NO | |
| RxCUI: 14688 | 4,4'-dihydroxybiphenyl | Designated preferred name (PT) | NO | |
| RxCUI: 14688 | 4,4'-dihydroxybiphenyl | Full form of descriptor (FN) | NO | |
| RxCUI: 1468845 | bosentan anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1468845 | bosentan anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1468845 | bosentan anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 14694 | Diphenylmethane 4,4-di-isocyanate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 14694 | Diphenylmethane 4,4-di-isocyanate | Designated preferred name (PT) | NO | |
| RxCUI: 14694 | Diphenylmethane 4,4-di-isocyanate | Full form of descriptor (FN) | NO | |
| RxCUI: 14694 | Diphenylmethane 4,4-di-isocyanate | Designated preferred name (PT) | NO | |
| RxCUI: 14694 | Diphenylmethane 4,4-di-isocyanate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 14694 | Diphenylmethane 4,4-di-isocyanate | Full form of descriptor (FN) | NO | |
| RxCUI: 14699 | Dihydroxydibutylether | Designated preferred name (PT) | NO | |
| RxCUI: 14699 | Dihydroxydibutylether | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 14699 | Dihydroxydibutylether | Full form of descriptor (FN) | NO | |
| RxCUI: 14699 | Dihydroxydibutylether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 14699 | Dihydroxydibutylether | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |